2 drugs will have higher copays starting in September

On Sept. 1, 2017, the following will become nonpreferred (Tier 3) drugs on our Blue Cross Blue Shield of Michigan and Blue Care Network commercial (non-Medicare) prescription drug plan drug lists:

Cipro^® HC
Pancreaze^®

Instead of Cipro HC, you can help your patients save money by prescribing one of these lower-cost alternatives:

Lower-cost alternatives	Tier	Copayment level
Neomycin/Polymixin B/ Hydrocortisone (Cortisporin Otic)	1	Generic
Otovel^®	2	Preferred brand
CiproDex^®	2	Preferred brand

Instead of Pancreaze, suggest these lower-cost alternatives:

Lower-cost alternatives	Tier	Copayment level
Creon^®	2	Preferred
Zenpep^®	2	Preferred

We’ve notified our affected prescription drug plan members of this change and encouraged them to speak with you about switching to a lower-cost drug. If they decide to continue filling their current prescription on or after Sept. 1, they’ll have a higher copayment.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2016 American Medical Association. All rights reserved.